68 results
8-K
CRVS
Corvus Pharmaceuticals Inc
6 May 24
Entry into a Material Definitive Agreement
4:11pm
and research and development and administrative expenses.
The Purchase Agreement contains customary representations, warranties and agreements
8-K
EX-99.1
CRVS
Corvus Pharmaceuticals Inc
6 May 24
Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2024 Financial Results
4:01pm
, 2024. Based on its current plans, Corvus expects its cash to fund operations into the fourth quarter of 2025.
Research and development expenses … ,
(unaudited)
Operating expenses:
Research and development
General and administrative
Total operating expenses
Loss from operations
Interest income
424B5
CRVS
Corvus Pharmaceuticals Inc
3 May 24
Prospectus supplement for primary offering
4:05pm
include capital expenditures and research and development and administrative expenses. See “Use of Proceeds” on page S-13 of this prospectus supplement … capital expenditures, research and development and administrative expenses.
The amounts and timing of our actual expenditures will depend on numerous
8-K
EX-99.1
yv9ot
19 Mar 24
Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
4:02pm
8-K
EX-99.1
9hrwfxa
7 Nov 23
Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2023 Financial Results
4:03pm
8-K
EX-99.1
ei5s6c03li3x
8 Aug 23
Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2023 Financial Results
4:01pm
8-K
EX-99.1
9t7x1 w9uvdyga
8 May 23
Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2023 Financial Results
4:01pm
8-K
EX-99.1
bvnt n1hvfhuafg5
3 Nov 22
Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2022 Financial Results
4:06pm
8-K
EX-99.1
dahuajw3628u
8 Aug 22
Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2022 Financial Results
4:05pm
8-K
EX-99.1
1zo 58027hbcpemwttel
5 May 22
Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2022 Financial Results
12:00am
8-K
EX-99.1
gng 5xkd0kg0yyqctm
10 Mar 22
Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2021 Financial Results
4:06pm